WHO SAGE Roadmap for prioritizing uses of COVID-19 vaccines
An approach to optimize the global impact of COVID-19 vaccines, based on public health goals, global and national equity, and vaccine access and coverage scenarios
Overview
This revised Roadmap takes into account increasing vaccine availability, vaccine coverage rates, and the evolving epidemiological situation including COVID-19 variants of concern. Scenarios in which vaccination coverage exceeds 50% of the population are considered, as are topics such as vaccine use in children and adolescents and prioritization of additional and booster doses in relation to vaccination coverage rates.
To assist countries in developing recommendations for optimized use of vaccines against COVID-19,priority-use groups for vaccination (both primary series and booster doses) are identified based on epidemiological scenarios, public health goals, and vaccine coverage scenarios.
This Roadmap builds on the WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination.
This document has been updated: Version 21 January 2022.
For translations of this document in other languages, click here.
Related document:
- Corrigenda for the WHO SAGE Roadmap for prioritizing uses of COVID-19 vaccines
- WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination
Archived versions:
- WHO SAGE Roadmap For Prioritizing Uses Of COVID-19 Vaccines In The Context Of Limited Supply. Version 16 July 2021
- WHO SAGE Roadmap For Prioritizing Uses Of COVID-19 Vaccines In The Context Of Limited Supply. Version 13 November 2020
- WHO SAGE Roadmap For Prioritizing Uses Of COVID-19 Vaccines In The Context Of Limited Supply. Version 20 October 2020